Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at 2018 Marijuana Business Conference in Las Vegas

SAN DIEGO, Nov. 8, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® will exhibit its line of award-winning cannabidiol (CBD) hemp oil products at the Marijuana Business Conference (MJ Biz Con) on Nov. 14-16 in Las Vegas.

MJ Biz Con, the largest cannabis conference in the world, is the preeminent conference to drive business deals and forge valuable connections with cannabis professionals in business today. The event will attract more than 20,000 cannabis professionals and 1,000 exhibitors at the Las Vegas Convention Center at 3150 Paradise Rd, Las Vegas, NV 89109.

“We are thrilled to exhibit at the premiere business to business networking event for the cannabis industry,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “With the demand for wholesale CBD at an all-time high, and overwhelming media interest in the cannabis industry after still more state victories in this week’s midterm elections, we trust this event will be a huge success on all fronts.”

HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay. A new version of HempMeds® Active-Relief Roll-On topical product with five times the amount of CBD content will also be on display along with the company’s full suite of CBD products at MJ Biz Con.

HempMeds® Spokesperson Nick Fishenden, a former pro-golfer who has been in the industry for over half a decade, will be in attendance to offer media interviews on the company’s products and the many benefits of CBD.

“It’s incredible have the opportunity to connect with media and other industry professionals at this year’s Marijuana Business Conference,” said HempMeds® Spokesperson Nick Fishenden. “As a former athlete who didn’t have the opportunity to use CBD when competing, I hope to help spread awareness on how beneficial it can be for active on-the-go consumers who wish to feel and perform their best.”

Visit HempMeds® at booth 4311 or contact [email protected] to schedule an onsite product media rundown or interview with HempMeds® Spokesperson Nick Fishenden.

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]